Register

Registration

Note : After Answered of Questionnaires / Survey Please Close it.
.

Krebs Biochemicals & Industries Ltd . Small Cap

BSE: 524518 | NSE: KREBSBIO
Pharmaceuticals
Live
20/04/2021 4:00:00 PM
112.00 4.60   (4.28%)
BSE: price shown with 5 mins delayed.
Prev. Close 107.40
Open Price 112.00
Volume Traded 1941.00

Fundamentals

Mar'09 Mar'10 Mar'11 Mar'12 Mar'14 Mar'15 Mar'16 Mar'17 Mar'18 Mar'19
Ajusted EPS(Rs.)
Net Sales (Rs. Cr.)
Adjusted Net Profit
Book Value/ Share(Rs.)
Cash Flow
Debt to Cash Flow from Operations
RONW
ROCE %
Net Operating Profit Margin %
Net Profit Margin %
Debt / Equity
Dividend Yield %
Mar'09 Mar'10 Mar'11 Mar'12 Mar'14 Mar'15 Mar'16 Mar'17 Mar'18 Mar'19
Ajusted EPS(Rs.) 0 0 0 0 0 0 0 0 0 0
Net Sales (Rs. Cr.) 51.2 46.23 72.45 70.76 11.45 0 0 0 0 1.29
Adjusted Net Profit -42.60 -3.59 -6.68 -17.44 -15.21 -4.32 -4.32 -10.79 -10.79 -16.60
Book Value/ Share(Rs.) 57.15 50.8 43.41 24.34 8.35 3.79 3.79 -4.8 -4.8 7.15
Cash Flow -0.25 0.09 -0.14 0.06 -0.10 0.02 5.95 0.02 5.95 -6.04
Debt to Cash Flow from Operations -21.58 -5.59 -18.65 11.75 -60.09 1.24 -1.35 1.24 -1.35 -2.00
RONW 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROCE % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Operating Profit Margin % -62.25 -5.68 -0.36 -12.73 -63.44 0.00 0.00 0.00 0.00 -839.01
Net Profit Margin % -78.06 -7.49 -8.53 -22.94 -125.72 0.00 0.00 0.00 0.00 -1157.45
Debt / Equity 1.14 1.73 2.00 2.70 5.75 16.10 16.10 7.04 7.04 2.92
Dividend Yield % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Year on Year Growth Rate (%)

Ajusted EPS Sales Adjusted Net Profit

Latest Financials

Standalone Consolidated
TTM EPS (Rs) 0
TTM Sales (Rs. Cr.) 35.75
BVPS (Rs.) -11.93
Reserves (Rs. Cr.) -47.28
P/BV -9.38
PE NM
From the Market
52 Week High / Low (Rs) 147.7/63.05
All Time High / Low (Rs) 304/9.42
Volume Traded 1941
Market Cap (Rs. Cr.) 231.56
Equity (Rs. Cr.) 21.560586
Face Value (Rs) 10
Industry PE 0

Quarterly Results

Mar'2020 Jun'2020 Sep'2020 Dec'2020
Net Sales (Cr) 10.22 7.68 11.39 6.46
Adjusted EPS (Rs) -3.42 -3.43 -3.26 -4.21
Net Profit Margin % -60.27 -87.50 -56.10 -127.86
Mar'2020 Jun'2020 Sep'2020 Dec'2020
Net Sales (Cr)
Adjusted EPS (Rs)
Net Profit Margin %

Quarterly Growth Rate (%)

Ajusted EPS Sales Net Profit Margin

Peers Data

Name Current Price(Rs) Market Cap. (Rs. cr.) Net Profit(Rs. cr.) Sales Growth(%)

Technical

Sector

23387.09 280.75   (1.22%)

Index

47705.80 -243.62   (-0.51%)
9 Days Avg
Span A Span B 52 Week TenKan-Sen Kijun-Sen ChiKou-Sen
9 Days Avg

Score

Kindly subscribe to get access

Research Analytical

Kindly subscribe to get access

News

About Company

Krebs Biochemicals & Industries Ltd[KBIL](Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same.KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. KBIL since inception, has adopted global agenda for its growth by focusing on its specific area of expetise 'Fermentation Technology'. During 2001-02, the company has successfully launched Vitamin C(I P Grade) through Fermentation Process.The company has also received ISO 9002 Certification for Unit I at Nellore from Yarsley International Certifications Services accredited by United Kingdom Accreditation Services. The company is now producing and marketing Lovastatin,Simvastatin and Vitamin-C. The company is now in the process of installing a co-generation power plant at Unit-II. As a step in the direction of backward integration and to capitalise on co-generation and Ethanol manufacturing the company has successfully bidded and acquired the Nannapaneni Venkatrao Co-operative Sugars Ltd located at Jampani in Guntur District of Andhra Pradesh from the Andhra Pradesh Government in Dec 28, 2003.